Transaminase Inhibition by 2-Hydroxyglutarate Impairs Glutamate Biosynthesis and Redox Homeostasis in Glioma

Cited by (361)

Items 201–300 of 361

1. Mutant IDH1 inhibitors activate pSTAT3-Y705 leading to an increase in BCAT1 and YKL-40 levels in mutant IDH1-expressing cells
   Debanjan Bhattacharjee, Balabhaskararao Kancharana, Nishant Jain · 2021 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
2. Metabolic Landscape of a Genetically Engineered Mouse Model of IDH1 Mutant Glioma
   Victor Ruiz‐Rodado, Tomohiro Seki, Tyrone Dowdy, Adrian Lita, Meili Zhang, Sue Han, Chunzhang Yang, Murali Krishna Cherukuri, Mark R. Gilbert, Mioara Larion · 2020 · Cancers
3. Critical role of antioxidant programs in enzalutamide-resistant prostate cancer
   Eliot B. Blatt, Karla Parra, Antje Neeb, Lorenzo Buroni, Denisa Bogdan, Wei Yuan, Yunpeng Gao, Collin Gilbreath, Alec Paschalis, Suzanne Carreira et al. · 2023 · Oncogene
4. Metabolic Profiles Point Out Metabolic Pathways Pivotal in Two Glioblastoma (GBM) Cell Lines, U251 and U-87MG
   Filipa Martins, David van der Kellen, Luís G. Gonçalves, Jacinta Serpa · 2023 · Biomedicines
5. Molecular biology and novel therapeutics for IDH mutant gliomas: The new era of IDH inhibitors
   Yosuke Kitagawa, Ami Kobayashi, Daniel P. Cahill, Hiroaki Wakimoto, Shota Tanaka · 2024 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
6. Integrative Analysis of Metabolomic and Transcriptomic Data Reveals Metabolic Alterations in Glioma Patients
   Yingying Shi, Daling Ding, Liwei Liu, Zhuolun Li, Lihua Zuo, Lin Zhou, Qiuzheng Du, Ziwei Jing, Xiaojian Zhang, Zhi Sun · 2021 · Journal of Proteome Research
7. Role of Glutamate Excitotoxicity in Glioblastoma Growth and Its Implications in Treatment
   Colin Moriarty, Natasha Gupta, Debanjan Bhattacharya · 2025 · Cell Biology International
8. Metabolism in the tumor microenvironment: implications for pathogenesis and therapeutics
   Jonas Aakre Wik, Emma Riiser Berge, Kristine Stromsnes, Bjørn Steen Skålhegg · 2025 · Frontiers in Immunology
9. Metabolic Rewiring in Adult-Type Diffuse Gliomas
   Jong‐Whi Park · 2023 · International Journal of Molecular Sciences
10. BCAA metabolism in cancer progression and therapy resistance: The balance between fuel and cell signaling
    Zhou Yi, Jiahui Kou, Wenjin Li, Yuyao Wang, Xingxing Su, Hongguang Zhang · 2025 · Frontiers in Pharmacology
11. Integration and Intersection of Cancer Metabolism with Epigenetic Pathways in Gliomas
    Siva Kumar Natarajan, Matthew J Pun, James Haggerty-Skeans, Sriram Venneti · 2025 · Annual Review of Pathology Mechanisms of Disease
12. Gut microbiota-derived l-theanine promotes host branched-chain amino acid catabolism
    Youxia Wang, Bingnan Liu, Ziyi Han, Peng Bin, Wenjie Tang, Jian Fu, Ifen Hung, Chunxue Liu, Hong Wei, Liangpeng Ge et al. · 2026 · Nature Microbiology
13. The curious case of IDH mutant acute myeloid leukaemia: biochemistry and therapeutic approaches
    Emily Gruber, Lev M. Kats · 2023 · Biochemical Society Transactions
14. Metabolic remodeling in astrocytes: Paving the path to brain tumor development
    Myriam Jaraíz-Rodríguez, Lucia del Prado, Eduardo Balsa · 2023 · Neurobiology of Disease
15. Metabolism: an important player in glioma survival and development
    Ning Wang, Yiru Yuan, Tianhao Hu, Huizhe Xu, Haozhe Piao · 2024 · Discover Oncology
16. Clinical Targeting of Altered Metabolism in High-Grade Glioma
    Andrew J. Scott, Costas Andreas Lyssiotis, Daniel Richard Wahl · 2021 · The Cancer Journal
17. Identifying Differential Expression Genes and Prognostic Signature Based on Subventricular Zone Involved Glioblastoma
    Qing Yuan, Fuxing Zuo, Hong‐Qing Cai, Hai-Peng Qian, Jinghai Wan · 2022 · Frontiers in Genetics
18. From Metabolism to Genetics and Vice Versa: The Rising Role of Oncometabolites in Cancer Development and Therapy
    Emanuela Di Gregorio, Gianmaria Miolo, Asia Saorin, Agostino Steffan, Giuseppe Corona · 2021 · International Journal of Molecular Sciences
19. Managing GSH elevation and hypoxia to overcome resistance of cancer therapies using functionalized nanocarriers
    Nelly M. Dabbour, Ahmed M. Salama, Thoria Donia, Radwa T. Al-Deeb, Abdullah M. Abd Elghane, Karima H. Badry, Samah A. Loutfy · 2021 · Journal of Drug Delivery Science and Technology
20. Nuclear IMPDH Filaments in Human Gliomas
    Narges Ahangari, David G. Muñoz, Josée Coulombe, Douglas A. Gray, Elizabeth C. Engle, Long Cheng, John Woulfe · 2021 · Journal of Neuropathology & Experimental Neurology
21. A 2-hydroxybutyrate-mediated feedback loop regulates muscular fatigue
    Brennan J. Wadsworth, Marina Leiwe, Eleanor Minogue, Pedro P. Cunha, Viktor Engman, Carolin Brombach, Christos Asvestis, Shiv K. Sah‐Teli, Emilia Marklund, Peppi Koivunen et al. · 2023 · eLife
22. Stable isotope-resolved metabolomics analyses of metabolic phenotypes reveal variable glutamine metabolism in different patient-derived models of non-small cell lung cancer from a single patient
    Connor Jarrett Kinslow, Michael Bousamra ll, Yihua Cai, Jun Yan, Pawel Lorkiewicz, Ahmad Al‐Attar, Jinlian Tan, Richard M. Higashi, Andrew N. Lane, Teresa W.‐M. Fan · 2024 · Metabolomics
23. Metabolic functions of misunderstood D-2-hydroxyglutarate
    Yidong Liu, Zhaoqi Kang, Wen Zhang, Cuiqing Ma, Ping Xu, Chao Gao · 2024 · The Innovation Life
24. Alpha-Lipoic Acid Prevents Side Effects of Therapeutic Nanosilver without Compromising Cytotoxicity in Experimental Pancreatic Cancer
    Xuefeng An, Li Liu, Michael Schaefer, Bin Yan, Christian Scholz, Stefan Hillmer, Kangtao Wang, Yiqiao Luo, Huihui Ji, Jury Gladkich et al. · 2021 · Cancers
25. (2R,3S)-Dihydroxybutanoic Acid Synthesis as a Novel Metabolic Function of Mutant Isocitrate Dehydrogenase 1 and 2 in Acute Myeloid Leukemia
    Jeffrey R. Idle, Katja Seipel, Ulrike Bacher, Thomas Pabst, Diren Beyoğlu · 2020 · Cancers
26. l-2-Hydroxyglutarate remodeling of the epigenome and epitranscriptome creates a metabolic vulnerability in kidney cancer models
    Anirban Kundu, Garrett J. Brinkley, Hyeyoung Nam, Suman Karki, Richard L. Kirkman, Madhuparna Pandit, Eun‐Hee Shim, Hayley Widden, Juan Liu, Yasaman Heidarian et al. · 2024 · Journal of Clinical Investigation
27. Suppressing PD-L1 Expression via AURKA Kinase Inhibition Enhances Natural Killer Cell-Mediated Cytotoxicity against Glioblastoma
    Trang Thi Thu Nguyen, Qiuqiang Gao, Jeong-Yeon Mun, Zhe Zhu, Chang Shu, Aaron Naim, Meri Rogava, Benjamin Izar, Mike‐Andrew Westhoff, Georg Karpel‐Massler et al. · 2024 · Cells
28. IDH Mutant Cholangiocarcinoma: Pathogenesis, Management, and Future Therapies
    Alexander Bray, Vaibhav Sahai · 2025 · Current Oncology
29. IDH mutant high-grade gliomas
    Santosh Valvi, Maryam Fouladi, Michael J. Fisher, Nicholas G. Gottardo · 2025 · Frontiers in Molecular Neuroscience
30. Association between altered metabolism and genetic mutations in human glioma
    Hannah Pearl, Candace C. Fleischer · 2023 · Cancer Reports
31. Molecular Profiling and Targeted Therapies in Gliomas
    Yuli Felistia, Patrick Yung Wen · 2023 · Current Neurology and Neuroscience Reports
32. Mechanism analysis and targeted therapy of IDH gene mutation in glioma
    Xingyuan Ma · 2025 · American Journal of Cancer Research
33. Combination strategies to target metabolic flexibility in cancer
    Jelena Krstić, Katharina Schindlmaier, Andreas Prokesch · 2022 · International review of cytology
34. Multi-omics analysis identifies BCAT2 as a potential pan-cancer biomarker for tumor progression and immune microenvironment modulation
    Qixuan Cao, Jie Fan, Jian Zou, Wei Wang · 2024 · Scientific Reports
35. Integrated analysis of transcriptional and metabolic responses to mitochondrial stress
    Liam P. Kelley, Songhua Hu, Sarah A. Boswell, Peter Karl Sorger, Alison Epstein Ringel, Marcia C. Haigis · 2025 · Cell Reports Methods
36. Glutaminase 1 inhibitors: Therapeutic potential, mechanisms of action, and clinical perspectives
    Hui Wang, Xiandeng Li, Haitao Hu, Zhan Gao · 2025 · Biochemical Pharmacology
37. Branched chain amino acids and their aberrant metabolism in cancer
    Morgan L. Brown, Xuanyan Cai, Marie Celeste Simon · 2025 · Trends in cancer
38. Mitochondrial VHL rewires cell metabolism in hypoxia
    Guobang Li, Wenfeng Pan, Long Wu, Zhiliang Cai, Haoming Chen, Xingui Wu, Tiantian Yu, Kun Liao, Hui Zhang, 温星桥 et al. · 2025 · Cell Metabolism
39. C-13 Hyperpolarized MR Spectroscopy for Metabolic Imaging of Brain Tumors
    Pavithra Viswanath, Yan Li, Sabrina M. Ronen · 2019 · Springer eBooks
40. Delivery of PARP inhibitors through 2HG-incorporated liposomes for synergistically targeting DNA repair in cancer
    Zhangyi Luo, Yixian Huang, Shangyu Chen, Bei Zhang, Haozhe Huang, Sheida Dabiri, Yuang Chen, Anju Zhang, Alexis R. Andreas, Song Li · 2024 · Cancer Letters
41. BCAT1 contributes to the development of TKI-resistant CML
    Yu Jiang, Difan Zhang, Xiaoxiao He, Chiqi Chen, Li Xie, Ligen Liu, Zhuo Yu, Ya‐Ping Zhang, Junke Zheng, Dan Huang · 2024 · Cellular Oncology
42. Oncogenic Mechanisms and Therapeutic Targeting of Metabolism in Leukemia and Lymphoma
    Maximilian F. Stahl, Zachary Drew Epstein-Peterson, Andrew M. Intlekofer · 2020 · Cold Spring Harbor Perspectives in Medicine
43. IDH1 mutation inhibits differentiation of astrocytes and glioma cells with low oxoglutarate dehydrogenase expression by disturbing α-ketoglutarate-related metabolism and epigenetic modification
    Yuanlin Zhao, Ying Li Yang, Risheng Yang, Chao Sun, Xing Gao, Xiwen Gu, Yuan Yuan, Ya-Ting Nie, Shenhui Xu, Ruili Han et al. · 2024 · Life Metabolism
44. Reprogrammed mitochondria: a central hub of cancer cell metabolism
    Fabio Ciccarone, Maria Rosa Ciriolo · 2024 · Biochemical Society Transactions
45. Unveiling the role of RNA methylation in glioma: Mechanisms, prognostic biomarkers, and therapeutic targets
    Qichen Xu, Chunsong Yang, Liyun Wang, Jing Zhou · 2024 · Cellular Signalling
46. Brain tumour histopathology through the lens of deep learning: A systematic review
    Chun Kiet Vong, Alan Wang, Mike Dragunow, Thomas Park, Vickie Shim · 2025 · Computers in Biology and Medicine
47. Unveiling the Maze: Branched-Chain Amino Acids Fueling the Dynamics of Cancer Metabolism and Progression
    Kai Xu, Pratham Viral Shah, Dhruvi Makhanasa, Md. Wasim Khan · 2025 · Cancers
48. State of the art: glioma-associated epilepsy—bridging tumor biology and epileptogenesis
    Iris Divé, Anna‐Luisa Luger, Dorothea Muench, Katharina Johanna Weber, Joachim P. Steinbach, Felix Rosenow, Frank Winkler, Pia Susann Zeiner · 2025 · Neurological Research and Practice
49. Ferroptosis in AML: nanoparticles, biomarkers, and immune rewiring for therapeutic breakthroughs
    Farzaneh Tavakoli, Mohammad A. Araskhan, Fatemeh Karimpour, Hamed Soleimani Samarkhazan, Hoda Hasheminasab, Elham Roshandel, Nader Vazifeh Shiran, Ali Dehghanifard, Mohammad Hossein Mohammadi · 2025 · Discover Oncology
50. LncRNA PSMB8-AS1 increases glioma malignancy via the miR-382-3p/BCAT1 axis
    Haibo Liu, Jie Zhang, Jiamin Li, Xiaoying Cao, Kai Yu, Xun Xia, Zongxi Li, Fengbo Wang · 2023 · Translational Oncology
51. Low-Grade Gliomas
    David Schiff · 2024 · Neurology
52. Aberrant BCAT1 expression augments MTOR activity and accelerates disease progression in chronic lymphocytic leukemia
    Qiangqiang Shao, Jedrzej Wykretowicz, Nan Hu, Karan Bedi, Mohamed Rizk, Isabella A. Malek, Surinder Kumar, David B. Lombard, Kerby Shedden, David A. Scott et al. · 2024 · Leukemia
53. IDH-Mutant Gliomas
    Kensuke Tateishi, Tetsuya Yamamoto · 2019 · IntechOpen eBooks
54. idh-1 neomorphic mutation confers sensitivity to vitamin B12 in Caenorhabditis elegans
    Olga Ponomarova, Alyxandra N. Starbard, Alexandra C. Belfi, Amanda V Anderson, Meera V. Sundaram, Albertha J.M. Walhout · 2024 · Life Science Alliance
55. TET enzymes: Involvement in cancer development and therapeutical perspectives
    Tarik Aanniz, Meriem El Fessikh, Jihane Touhtouh, Sara Aboulaghras, Nasreddine El Omari, Asaad Khalid, Ashraf N. Abdalla, Mohammed Rizwan Amanullah, Bey Hing Goh, Learn−Han Lee et al. · 2025 · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
56. Metabolism and therapeutic response in acute myeloid leukemia with IDH1/2 mutations
    Ludovic Gabellier, Enzo Bosetta, Maël Heiblig, Jean‐Emmanuel Sarry · 2025 · Trends in cancer
57. Nanotechnology-driven strategies in postoperative cancer treatment: innovations in drug delivery systems
    Junjie Zhou, Yan-Chuan Feng, Min-Long Zhao, Qi Guo, Xibo Zhao · 2025 · Frontiers in Pharmacology
58. Generation of induced neural stem cells with inducible IDH1R132H for analysis of glioma development and drug testing
    Kamila Rosiak, Dagmara Grot, Piotr Rieske · 2020 · PLoS ONE
59. Tumor evolution-targeted nanomedicineEVT
    Lingpu Zhang, Jia‐Zhen Yang, Dongsheng Tang, Hanchen Zhang, Jianxun Ding, Haihua Xiao · 2022 · Scientia Sinica Chimica
60. The role of branched-chain aminotransferase 1 in driving glioblastoma cell proliferation and invasion varies with tumor subtype
    Maria Fala, Susana R�os, Ashley Sawle, Jyotsna Upendra Rao, Anastasia Tsyben, Laura Tronci, Christian Frezza, Richard James Mair, Kevin Michael Brindle · 2023 · Neuro-Oncology Advances
61. In vivo characterization of physiological and metabolic changes related to isocitrate dehydrogenase 1 mutation expcression by multiparametric MRI and MRS in a rat model with orthotopically grafted human‐derived glioblastoma cell lines
    Alexandra Clément, Matthieu Doyen, Florence Fauvelle, Gabriela Hossu, Bailiang Chen, Muriel Barberi‐Heyob, Alex Hirtz, Vasile Stupar, Zohra Lamiral, Celso Pouget et al. · 2021 · NMR in Biomedicine
62. Conditional Covalent Lethality Driven by Oncometabolite Accumulation
    Minervo Perez, Kellie D. Nance, Daniel W. Bak, Supuni Thalalla Gamage, Susana Sarai Najera, Amy N. Conte, William Marston Linehan, Eranthie Weerapana, Jordan L. Meier · 2022 · ACS Chemical Biology
63. Mitochondria transfer in glioblastoma
    Simon Storevik, Mina Thue Augustsson, Shannon Sherwin Moreino, Hanjo Köppe, Dionysios Christos Watson, Defne Bayık, Carolina De La Pena Fernandez, Amanda M Serapiglia, Nikhil Panicker, Justin Durla Lathia et al. · 2026 · Neuro-Oncology
64. Association between accumulation of 2-hydroxyglutarate detected by MR spectroscopy and preoperative seizure in IDH-mutant glioma
    Hiroaki Nagashima, Kazuhiro Tanaka, Shunsuke Yamanishi, Mitsuru Hashiguchi, Hirofumi Iwahashi, Takiko Uno, Yuichiro Somiya, Masato Komatsu, Tomoo Itoh, Ryohei Sasaki et al. · 2024 · Journal of neurosurgery
65. Determination of intracellular 2-hydroxyglutarate enantiomers using two-dimensional liquid chromatography
    Takuma Ohtawa, Ayuna Hattori, Muneki Isokawa, Masashi Harada, Takashi Funatsu, Takahiro Ito, Makoto Tsunoda · 2021 · Journal of Chromatography Open
66. Leveraging insights into cancer metabolism—a symposium report
    Jennifer Cable, Lydia W.S. Finley, Benjamin P. Tu, Gary J. Patti, Trudy G. Oliver, Santosha Adipudi Vardhana, Miyeko Mana, Russell Erick Ericksen, Sanika Khare, Ralph J. DeBerardinis et al. · 2019 · Annals of the New York Academy of Sciences
67. Nitrogen metabolism profiling reveals cell state-specific pyrimidine synthesis pathway choice
    Milan R. Savani, Bingbing Li, Bailey C. Smith, Wen Gu, Yi Xiao, Gerard Baquer, Tracey E. Shipman, Skyler Oken, Namya Manoj, Lauren G. Zacharias et al. · 2026 · Nature Metabolism
68. Rewiring amino acids in cancer
    Yiqing Zhang, Jianxin Lyu, Hezhi Fang · 2025 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
69. Targeting Metabolic Vulnerabilities in Glioblastoma: a Framework for Multi-node Combination Therapy
    Vishal Gokani, Anuhya Kotta, Venkata Repaka, Sukanya Rauniyar, Evan Noch · 2026 · Current Oncology Reports
70. Neuro-tumor-immune crosstalk in pancreatic cancer: Mechanisms and therapeutic insights.
    Jian-Guo Jin, Bin He, Xiang Wang, Yuqian Zhang, Huiming You, Sirui Mo, Duancheng Guo, Saimeng Shi · 2026 · Biochimica et biophysica acta. Reviews on cancer
71. Ivosidenib and Vorasidenib Decrease Intratumoral 2-Hydroxyglutarate and Total Choline Levels in Patients with Lower-Grade Glioma: An In Vivo MR Spectroscopy Study
    Dunja Simičić, Şeyma Alçiçek, Lindsay Blair, Max A. Saint-Germain, Helge J. Zöllner, Zsombor Ritter, Jaishri O'Neill Blakeley, Christopher W. Davies‐Jenkins, Matthias Holdhoff, John Laterra et al. · 2026 · Clinical Cancer Research
72. Isocitrate Dehydrogenase Mutations in Cancer: From Bench to Bedside Applications
    Yuhan Fang, Xiaoqing Wang, Kai Luo, Tikam Chand Dakal, He Bai, Caiming Xu, Guixin Zhang · 2026 · MedComm
73. Current and emerging therapies in IDH-mutant glioma
    Vihang Nakhate, Gilbert Youssef, Patrick Yung Wen · 2026 · Neurotherapeutics
74. Metabolism-Associated DNA Methylation Signature Stratifies Lower-Grade Glioma Patients and Predicts Response to Immunotherapy
    Guozheng Yang, Dezhi Shan, Rongrong Zhao, Gang Li · 2022 · Frontiers in Cell and Developmental Biology
75. Phospholipid metabolic adaptation promotes survival of IDH2 mutant acute myeloid leukemia cells
    Tatsuya Morishima, Koichi Takahashi, Desmond Wai Loon Chin, Yuxin Wang, Kenji Tokunaga, Yuichiro Arima, Masao Matsuoka, Toshio Suda, Hitoshi Takizawa · 2023 · Cancer Science
76. A glutamatergic biomarker panel enables differentiating Grade 4 gliomas/astrocytomas from brain metastases
    Falko Lange, Richard Gade, Anne Einsle, Katrin Porath, Gesine Reichart, Claudia Maletzki, Björn Schneider, Christian Henker, Daniel Dubinski, Michael Linnebacher et al. · 2024 · Frontiers in Oncology
77. To enhance the ex vivo expansion of CAR-NK-92 cells by regulating intracellular redox status
    Huimin Huang, Guofeng Zhang, Yuanyuan Zhao, Wen‐Song Tan, Haibo Cai · 2024 · Process Biochemistry
78. Targeting Tumor Metabolism to Overcome Radioresistance
    Daniel Richard Wahl, Michael S. Petronek, Ramachandran Rashmi, John M. Floberg, Bryan G. Allen, Julie Kristina Schwarz · 2020 · Cancer drug discovery and develogment/Cancer drug discovery and development
79. Epithelial-to-mesenchymal transition activates Bcat1 expression to promote recurrent tumor growth
    Douglas B. Fox, James V. Alvarez · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
80. A hybrid [18F]fluoropivalate PET-multiparametric MRI to detect and characterise brain tumour metastases based on a permissive environment for monocarboxylate transport
    S. Islam, Marianna Inglese, Preetha Aravind, Tara D. Barwick, Francesco Angelo Mauri, Laura McLeavy, Erik Årstad, J. Wang, Ignazio Puccio, L. Hung et al. · 2025 · European Journal of Nuclear Medicine and Molecular Imaging
81. ABCC10-mediated cGAMP efflux drives cancer cell radiotherapy resistance
    Zhengyang Zhang, Jie Gao, Xiang Liao, Zining Zhang, Xiongfeng Cao, Yi Gong, Wenlong Chen, Lirong Zhang, Hsiang‐i Tsai, Dongqing Wang et al. · 2025 · Cell Death and Differentiation
82. Leveraging cancer metabolism to translate into effective therapeutics
    Jie Xu, Linlin Guo, Yi Wang, Xiaoping Li, Ping Yi, Chunming Cheng · 2025 · Seminars in Cancer Biology
83. IDH1 Reprograms Nucleotide Metabolism by Inducing Chromatin Remodeling and DHODH Transcription to Drive Chemoresistance in Nasopharyngeal Carcinoma
    Yuheng Zhao, Chunxian Ou, Huimin Huang, Yujue Wang, Jiaxi Shen, Yaoyi Li, Qing‐Mei He, Zeteng Han, Yuer Xie, Tianyun Zhong et al. · 2026 · Cancer Research
84. Tumor-derived branched-chain α-keto acids activate Notch signaling in tumor-associated macrophages to limit immunity
    Qixiang Ma, Ru Zhao, Jiangxue Han, Wen-Ying Zhu, Mi‐die Xu, Xiao-Yan Zhang, Guoquan Yan, Wenyu Wen, Guang-Chun Han, Min Luo et al. · 2026 · Nature Immunology
85. Emerging roles of ferroptosis in modulating the immune landscape of glial tumours
    Michael Argenziano, Taruna V. Neelakantan, Colin P. Sperring, Oluwaseyi O. Adeuyan, Dominique M. O. Higgins, Jeffrey N. Bruce, Betty Y.S. Kim, Athanassios Dovas, Peter Canoll, Michael K. Lim et al. · 2026 · Nature Cell Biology
86. Metabolic models predict fotemustine and the combination of eflornithine/rifamycin and adapalene/cannabidiol for the treatment of gliomas
    Ali Kishk, Maria Pires Pacheco, Tony Heurtaux, Thomas Sauter · 2024 · Briefings in Bioinformatics
87. Discovery of Aloperine as a Potential Antineoplastic Agent for Cholangiocarcinoma Harboring Mutant IDH1
    Xingkang Wu, Yang Li, Chenchen Han, Shi-Fei Li, Xuemei Qin · 2024 · International Journal of Molecular Sciences
88. A lanthanide complexes-based endoplasmic reticulum-targetable probe for ratiometric time-gated luminescence detection and imaging of reactive sulfur species in vitro and in vivo
    Tao Wang, Bo Song, Deshu Kong, Wenzhu Zhang, Jingli Yuan · 2025 · Journal of Rare Earths
89. Metabolic biomarkers of radiotherapy response in plasma and tissue of an IDH1 mutant astrocytoma mouse model
    Victor Ruiz‐Rodado, Tyrone Dowdy, Adrian Lita, Tamalee R. Kramp, Meili Zhang, Dorela D. Shuboni‐Mulligan, Christel C. Herold‐Mende, Terri S. Armstrong, Mark R. Gilbert, Kevin A. Camphausen et al. · 2022 · Frontiers in Oncology
90. Ivosidenib for the treatment of relapsed or refractory acute myeloid leukemia with an IDH1 mutation
    Florence Pasquier, Claude Chahine, Christophe Marzac, Stéphane de Botton · 2020 · Expert Review of Precision Medicine and Drug Development
91. Potential of Polyphenolic Nutraceuticals in the Management of Glioblastoma Multiforme
    Swati Devendra Raysing, Ashish Prakash Gorle · 2022 · Current Nutraceuticals
92. Targeting IDH2 promotes antitumor immunity through epigenetic activation of cGAS-STING pathway
    Jiangjiang Li, Xinghua Zhen, Lulu Liu, Xueling Yan, Lingzhi Wu, Xiangjian Luo, Pumin Zhang · 2025 · Lung Cancer
93. Ammonia in cancer: dual roles and therapeutic strategies
    Jinhui Wei, Yue Chen, Qiang Li, Fuxin Huang, Chuanzhao Zhang, Baohua Hou, Shanzhou� Huang · 2025 · Cancer Cell International
94. Branched-chain amino acid transaminases as promising targets in tumor therapy
    Wen Zhang, Jie Shen, Xuanyin Ding, Hele Liu, Xu Wang, Dan Feng · 2026 · Frontiers in Cell and Developmental Biology
95. Targeting the Keap1/Nrf2 axis in cancer: molecular mechanisms and pharmacological interventions
    Yangchen Xia, Ziyang Xu, Xun Yuan, Qian Chu · 2025 · Investigational New Drugs
96. The Distribution and Significance of IDH Mutations in Gliomas
    Nu Thien Nhat Tran · 2022 · IntechOpen eBooks
97. FYN-mediated phosphorylation of BCKDK at Y151 promotes GBM proliferation by increasing the oncogenic metabolite N-acetyl-L-alanine
    Ling Zou, Wei Wang, Wenda Huang, Xiaofang Ni, Wensheng Li, Yue Cheng, Qin Tian, Lin Liu, Feng Zhu, Qiuhong Duan · 2024 · Heliyon
98. Metabolic checkpoints in glioblastomas: targets for new therapies and non-invasive detection
    Wenhao Li, Zhihao Wang, Siliang Chen, Mingrong Zuo, Yufan Xiang, Yunbo Yuan, Yuze He, Shuxin Zhang, Yanhui Liu · 2024 · Frontiers in Oncology
99. α-Ketoglutarate promotes amino acid depletion and suppresses B-cell lymphoma growth and development
    Carine Jaafar, Purushoth Ethiraj, Zhijun Qiu, An‐Ping Lin, Pedro S. S. M. Ferrari, Ricardo C.T. Aguiar · 2025 · Blood
100. It takes two to tango: IDH mutation and glutaminase inhibition in glioma
     Qing Hua Zhang · 2018 · Science Translational Medicine